Search results
12 de abr. de 2024 · A high-level overview of AbCellera Biologics Inc. (ABCL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
12 de abr. de 2024 · Detailed annual and quarterly income statement for AbCellera Biologics Inc. (ABCL). See many years of revenue, expenses and profits or losses.
Hace 2 días · ABCL Earnings Date and Information. AbCellera Biologics last announced its quarterly earnings results on February 20th, 2024. The reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.14) by $0.03. The business had revenue of $9.18 million for the quarter, compared to the consensus estimate of $9.58 million.
Hace 6 días · Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have earned a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports.Seven analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have covered the stock in the last year is $15.86.
Hace 4 días · Find out if AbCellera Biologics Inc Ordinary Shares (ABCL:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the...
Hace 6 días · Get Abcellera Biologics Inc (ABCL.B) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments
Hace 4 días · View AbCellera Biologics (NASDAQ:ABCL) historical prices, past price performance, and an advanced ABCL stock chart at MarketBeat.
